Intelligence Profile
Research Papers
Research on daratumumab focuses on its application in various conditions, primarily multiple myeloma and certain transplant rejections.
Kidney Allograft Rejection: A study in the Clinical Kidney Journal examined daratumumab's effects in antibody-mediated kidney allograft rejection. Using serial protocol biopsies, the study highlighted its potential therapeutic role, although detailed methodology such as sample size was not specified.
Multiple Myeloma: Several studies focus on daratumumab for newly diagnosed and relapsed multiple myeloma. A paper from the Zhongguo Shi Yan Xue Ye Xue Za Zhi applied a multi-model study and clinical decision analysis to assess early death risk in newly diagnosed patients treated with daratumumab. Additionally, a retrospective analysis in the Asia-Pacific Journal of Clinical Oncology reviewed its use in relapsed or refractory cases in Australia, indicating effectiveness but lacking detailed quantitative data.
Iron Deficiency and Treatment Complications: The British Journal of Haematology noted a high prevalence of iron deficiency among newly diagnosed multiple myeloma patients treated with daratumumab, suggesting the need for monitoring and management strategies.
Treatment-Related Reactions: A prospective observational study in the Biological & Pharmaceutical Bulletin compared non-sedating and sedating antihistamines as premedications to prevent infusion-related reactions, highlighting options to minimize adverse effects during subcutaneous administration.
Smoldering Multiple Myeloma: A phase II trial (NCT03236428) is currently not recruiting but is investigating daratumumab in high-risk MGUS and low-risk smoldering multiple myeloma, reflecting ongoing interest in its early-intervention potential.
Overall, clinical trials and papers show that daratumumab is extensively studied in multiple myeloma, with additional explorations in rejection management and safety improvements.
Disclaimer: This summary is for informational purposes only and not a substitute for professional medical advice.